A randomized phase II trial of Prostate Boost irradiation with Stereotactic body radiotherapy (SBRT) vs conventional fraction (CF) fractionation external beam radiotherapy (EBRT) in localized high risk prostate cancer.The PBS trial (NCT03380806)
CLINICAL GENITOURINARY CANCER(2020)
摘要
Standard therapy for high-risk (HR) prostate cancer (PrCa) involves androgen deprivation therapy (ADT) and pelvic conventional fractionation (CF) external beam radiotherapy (EBRT) followed by boost CF-EBRT treatment to prostate f or a total of 78 to 80 Gy in 39 to 40 fractions. This is a long and inconvenient treatment for patients. Brachytherapy boost treatment studies indicate that escalation of biological dose of radiotherapy (RT) can improve outcomes in HR-PrCa. However, brachytherapy is an invasive treatment associated with increased toxicity and requires specialized resources. Stereotactic body radiotherapy (SBRT) is a promising, non-invasive alternative to brachytherapy. However, i ts impact on patient quality of life (QoL) and RT-associated toxicity has not been investigated in a randomized setting. I n this study, we investigate SBRT as a boost treatment, following pelvic CF-EBRT, in patients with HR-PrCa treated with ADT. One hundred patients with locally advanced PrCa will be randomized to receive daily CF-EBRT of 45 to 46 Gy in 23 to 25 fractions followed by either daily CF-EBRT of 32 to 33 Gy in 15 to 16 fractions (control arm) or SBRT boost treatment of 19.5 to 21 Gy in 3 fractions (1 fraction per week) (experimental arm). The primary objective of the PBS trial is early bowel and urinary QoL (expanded prostate index composite [EPIC], up to 6 months after RT). This phase II randomized study (PBS) provides an appropriate setting to investigate effectively the impact of SBRT boost on QoL and toxicity in patients with HR-PrCa, before this modality can be compared against the current standard of care in larger phase III protocols. (C) 2020 Elsevier Inc. All rights reserved.
更多查看译文
关键词
Androgen deprivation therapy,High risk prostate cancer,Quality of life,Radiotherapy toxicity
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络